Cargando…
Proteinuria in COVID-19
Upper respiratory and pulmonary diseases are the primary manifestations of coronavirus disease 2019 (COVID-19). However, kidney involvement has also been recognized and extensively described. A large percentage of affected patients present with acute kidney injury (AKI). However, specific phenotypic...
Autores principales: | Mohamed, Muner M B, Velez, Juan Carlos Q |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995522/ https://www.ncbi.nlm.nih.gov/pubmed/33815781 http://dx.doi.org/10.1093/ckj/sfab036 |
Ejemplares similares
-
SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence
por: Kalay, Zeynepgul, et al.
Publicado: (2022) -
Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020) -
Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021) -
Kidney transplantation and COVID-19 renal and patient prognosis
por: Toapanta, Néstor, et al.
Publicado: (2021) -
Acute tubulointerstitial nephritis and COVID-19
por: Ng, Jia H, et al.
Publicado: (2021)